|
[1]
|
Craven, L., Alston, C.L., Taylor, R.W. and Turnbull, D.M. (2017) Recent Advances in Mitochondrial Disease. Annual Review of Genomics and Human Genetics, 18, 257-275. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hsu, P., Chu, C., Lin, T., Lu, Y., Lee, C., Lai, W., et al. (2008) Adult-Onset Hypertrophic Cardiomyopathy Manifested as Initial Major Presentation of Mitochondrial Disease with A-to-G 3243 tRNA Leu(uur) Point Mutation. International Journal of Cardiology, 129, 441-443. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kisler, J.E., Whittaker, R.G. and Mcfarland, R. (2010) Mitochondrial Diseases in Childhood: A Clinical Approach to Investigation and Management. Developmental Medicine & Child Neurology, 52, 422-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Holmgren, D. (2003) Cardiomyopathy in Children with Mitochondrial Disease Clinical Course and Cardiological Findings. European Heart Journal, 24, 280-288. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Scaglia, F., Towbin, J.A., Craigen, W.J., Belmont, J.W., Smith, E.O., Neish, S.R., et al. (2004) Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients with Mitochondrial Disease. Pediatrics, 114, 925-931. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Levinger, L., Oestreich, I., Florentz, C. and Mörl, M. (2004) A Pathogenesis-Associated Mutation in Human Mitochondrial Trnaleu(uur) Leads to Reduced 3’-End Processing and CCA Addition. Journal of Molecular Biology, 337, 535-544. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Silvestri, G., Santorelli, F.M., Shanske, S., Whitley, C.B., Schimmenti, L.A., Smith, S.A., et al. (1994) A New mtDNA Mutation in the Trnaleu(uur) Gene Associated with Maternally Inherited Cardiomyopathy. Human Mutation, 3, 37-43. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bruno, C., Kirby, D.M., Koga, Y., Garavaglia, B., Duran, G., Santorelli, F.M., et al. (1999) The Mitochondrial DNA C3303T Mutation Can Cause Cardiomyopathy and/or Skeletal Myopathy. The Journal of Pediatrics, 135, 197-202. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Lev, D., Nissenkorn, A., Leshinsky-Silver, E., Sadeh, M., Zeharia, A., Garty, B., et al. (2004) Clinical Presentations of Mitochondrial Cardiomyopathies. Pediatric Cardiology, 25, 443-450. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Assomull, R.G., Prasad, S.K., Lyne, J., Smith, G., Burman, E.D., Khan, M., et al. (2006) Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy. Journal of the American College of Cardiology, 48, 1977-1985. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Meyers, D.E., Basha, H.I. and Koenig, M.K. (2013) Mitochondrial Cardiomyopathy: Pathophysiology, Diagnosis, and Management. The Texas Heart Institute Journal, 40, 385-394.
|
|
[12]
|
Pompei, M. and Pompei, F. (2018) Overcoming Bioethical, Legal, and Hereditary Barriers to Mitochondrial Replacement Therapy in the Usa. Journal of Assisted Reproduction and Genetics, 36, 383-393. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Tarnopolsky, M.A., Roy, B.D. and MacDonald, J.R. (1997) A Randomized, Controlled Trial of Creatine Monohydrate in Patients with Mitochondrial Cytopathies. Muscle & Nerve, 20, 1502-1509. [Google Scholar] [CrossRef]
|